SEC Form 4Coverage since Jun 18, 2026
$CRDF insider trading
Over the last 12 months, Cardiff Oncology insiders reported 4 buys totaling $1.1M and no sales across SEC Form 4 filings.
- Bought · 12m
- $1.1M 4 events
- Sold · 12m
- — 0 events
- Events · 12m
- 4 Form 4 filings, grouped
- Insiders · 12m
- 2 distinct reporters
- 10b5-1 share
- 0% pre-arranged plans
Side
Price · $CRDF · 12Mvia TradingView
Top insiders · 12m
PACE GARY W—2× · $1.0M
Mohindru ManiChief Executive Officer2× · $80K
All insider trades
4 events
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jul 14, 2026 | PACE GARY WD | ▲ Buy | 687,285 | $1.46 | $1000K | +50.7% | — |
| Jul 14, 2026 | Mohindru ManiChief Executive Officer · O·D | ▲ Buy | 34,364 | $1.46 | $50K | +139.1% | — |
| Jun 18, 2026 | Mohindru ManiChief Executive Officer · O·D | ▲ Buy | 24,703 | $1.21 | $30K | — | — |
| Jun 18, 2026 | PACE GARY WD | ▲ Buy | 30,000 | $1.22 | $37K | +2.3% | — |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $CRDF feed.